Offer to Purchase, dated February 21, 2023.
|
|
|
|
Owl Rock Capital Corporation II
Ameriprise Financial Services, LLC Tender Offer Instruction
Letter |
|
|
To Our Clients,
This letter serves to inform you of important
information and instructions relating to the repurchase offer by Owl Rock Capital Corporation II (the “Company”), filed with the Securities and Exchange Commission on February 21, 2023, for $10,000,000. The term
“Shares” as used herein refers only to those shares of Common Stock that are eligible to be repurchased. The Company’s Offer is not conditioned on any minimum number of shares being tendered but is subject to other conditions
as described in the Offer and in the related Letter of Transmittal. Please refer to the Offer to Purchase and Letter of Transmittal for a complete description of the terms and conditions of this Offer. All capitalized terms not defined herein are
defined in the Offer to Purchase and Letter of Transmittal.
If you DO NOT wish to sell your shares of the Company, no action is required, and you can
disregard this notice.
Ameriprise Financial Services, LLC (“AMPF”) is the registered holder of record of Shares held for your account. As
the registered holder of record of the Shares held for your account, only AMPF may tender those shares pursuant to your instructions. Should you wish to participate in this tender offer, please take the following actions:
| |
1. |
Complete and Execute the enclosed Tender Authorization Form. |
| |
2. |
Return the signed Form to AMPF for their approval through one of the following three methods:
|
| |
b. |
Mail to 70400 Ameriprise Financial Center, Minneapolis, MN 55474 |
| |
c. |
Provide to your financial representative who will submit via eFile |
Your instructions to AMPF should be completed in ample time before the Expiration Date to permit AMPF enough time to submit a tender on your behalf before
the Expiration Date.
Should you have any questions regarding your investment, please contact your financial representative.
EX-99(a)(1)(B)
OFFER TO PURCHASE FOR CASH
BY OWL ROCK CAPITAL CORPORATION II
SHARES OF COMMON STOCK
AT A PURCHASE PRICE EQUAL TO THE PRICE PER SHARE IN EFFECT
AS OF MARCH 29, 2023
THE OFFER WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON
MARCH 27, 2023, UNLESS THE OFFER IS EXTENDED.
To the Shareholders of Owl Rock Capital Corporation II:
Owl
Rock Capital Corporation II, an externally-managed closed-end management investment company that has elected to be regulated as a business development company under the U.S. Investment Company Act of 1940, as
amended (“1940 Act”), and is incorporated in Maryland (the “Company,” “Owl Rock II,” “our,” “we,” or
“us”) is offering to purchase up to the number of shares of our issued and outstanding common stock, par value $0.01 per share (“Common Stock”), that can be repurchased with $10,000,000. The term
“Shares” as used herein refers only to those shares of Common Stock that are eligible to be repurchased. The purpose of this Offer to Purchase is to provide shareholders with the potential for a measure of liquidity, since
there otherwise is no public market for our Common Stock. See Section 2 below. The Offer is for cash at a price equal to the price per Share in effect for purposes of issuing Shares pursuant to our distribution reinvestment plan
(“DRIP”) as of March 29, 2023 (the “Purchase Price”), and is made upon the terms and subject to the conditions set forth in this Offer to Purchase and the related Letter of Transmittal (which
together with any amendments or supplements thereto, collectively constitute the “Offer”). The Offer will expire at 11:59 P.M., Eastern Time, on March 27, 2023 (the “Expiration Date”), unless
extended.
THE OFFER IS NOT CONDITIONED ON ANY MINIMUM NUMBER OF SHARES BEING TENDERED. THE OFFER IS, HOWEVER, SUBJECT TO OTHER CONDITIONS. SEE SECTION
3 BELOW.
IMPORTANT INFORMATION
Shareholders who desire to tender their Shares should properly complete and sign the Letter of Transmittal, including any required signature guarantee(s), and
mail or deliver it and any other documents required by the Letter of Transmittal. The Company reserves the absolute right to reject tenders determined not to be in appropriate form, subject to the rights of tendering shareholders to challenge the
Company’s determination in a court of competent jurisdiction.
IF YOU DO NOT WISH TO TENDER YOUR SHARES, YOU NEED NOT TAKE ANY ACTION.
NEITHER THE COMPANY, ITS BOARD OF DIRECTORS (THE “BOARD”) NOR OWL ROCK CAPITAL ADVISORS LLC (THE
“ADVISER”) MAKES ANY RECOMMENDATION TO ANY SHAREHOLDER AS TO WHETHER TO TENDER OR REFRAIN FROM TENDERING SHARES. NO PERSON HAS BEEN AUTHORIZED TO MAKE ANY RECOMMENDATION ON BEHALF OF THE COMPANY, ITS BOARD OR THE
ADVISER AS TO WHETHER SHAREHOLDERS SHOULD TENDER OR REFRAIN FROM TENDERING SHARES PURSUANT TO THE OFFER OR TO MAKE ANY REPRESENTATION OR TO GIVE ANY INFORMATION IN CONNECTION WITH THE OFFER OTHER THAN AS CONTAINED HEREIN OR IN THE ACCOMPANYING
LETTER OF TRANSMITTAL. IF MADE OR GIVEN, ANY SUCH RECOMMENDATION, REPRESENTATION OR INFORMATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY, ITS BOARD OR THE ADVISER. SHAREHOLDERS ARE URGED TO EVALUATE CAREFULLY ALL INFORMATION
IN THE OFFER, CONSULT THEIR OWN INVESTMENT AND TAX ADVISERS AND MAKE THEIR OWN DECISIONS WHETHER TO TENDER OR REFRAIN FROM TENDERING THEIR SHARES.
Neither the U.S. Securities and Exchange Commission nor any state securities commission nor any other regulatory
authority has approved or disapproved of these transactions or determined if the information contained herein is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this Offer to Purchase is February 21, 2023.
The Offer does not constitute an offer to buy or the solicitation of an offer to sell securities in any circumstance or jurisdiction in which such offer or
solicitation is unlawful. The delivery of the Offer materials shall not under any circumstances create any implication that the information contained therein is current as of any time subsequent to the date of such information.
SUMMARY TERM SHEET
(Section references are to this Offer to Purchase)
This Summary Term Sheet highlights the material information concerning this Offer. For a more complete discussion of the terms and conditions of the Offer,
you should read carefully the entire Offer to Purchase and the related Letter of Transmittal, which will be mailed to shareholders on or before February 28, 2023.
What is the Offer?
| |
• |
|
We are offering to purchase up to the amount of Shares that can be repurchased with $10,000,000. The Offer is for
cash at a price per Share equal to the price per Share in effect for purposes of issuing Shares pursuant to our DRIP as of March 29, 2023 (the “Purchase Price”). |
Why is the Company making the tender offer?
| |
• |
|
The Offer is designed to provide our shareholders with the potential for a measure of liquidity since there is
otherwise no public market for the Shares. We will conduct this repurchase offer to allow shareholders to tender their shares of our Common Stock at the price per Share in effect for purposes of issuing Shares pursuant to our DRIP on the date of
repurchase. This repurchase offer is being made at the discretion of the Board and subject to applicable law, including Section 23(c) of the 1940 Act and Rule 13e-4 under the U.S. Securities Exchange Act
of 1934, as amended (the “Exchange Act”). Subject to the Board’s discretion, we intend to conduct quarterly tender offers in accordance with the requirements of Rule 13e-4 under
the Exchange Act and the 1940 Act. The Board has complete discretion to determine whether we will engage in any share repurchase and, if so, the terms of such repurchase. See Section 2 below. |
When will the Offer expire, and may the Offer be extended?
| |
• |
|
The Offer will expire at 11:59 P.M., Eastern Time, on March 27, 2023, unless extended. We may extend the
period of time the Offer will be open by issuing a press release or making some other public announcement by no later than the next business day after the Offer otherwise would have expired. See Section 14 below. |
What is the most recent price per Share?
| |
• |
|
On February 20, 2023, our most recent price per Share, which was the price at which we last issued Shares
pursuant to our DRIP, was $8.89. |
Are there conditions to the Offer?
| |
• |
|
Yes. Our obligation to accept for payment and pay for the Shares in the Offer is subject to a number of
conditions that must be satisfied or waived (to the extent permitted by law) on or prior to the expiration of the Offer. See Section 3 below for a more complete description of the conditions to the Offer. |
Additionally, if the amount of repurchase requests exceeds the number of Shares we seek to repurchase, we may, in our sole discretion, either
accept the additional duly tendered Shares permitted to be accepted pursuant to Rule 13e-4(f)(1)(ii) under the Exchange Act, or repurchase Shares on a pro rata basis in accordance with the number of
Shares tendered by each shareholder (and not timely withdrawn).
How do I tender my Shares?
| |
• |
|
Once you receive the Offer materials, which consists of the Offer to Purchase, the related Letter of Transmittal
and any amendments or supplements thereto, you should read them, and if you should decide to tender, complete and submit a Letter of Transmittal and submit any other documents required by the Letter of Transmittal. These materials must be received
by us at the address listed on 10, in proper form, before 11:59 P.M., Eastern Time, on March 27, 2023 (unless the Offer is extended by us, in which case the new deadline will be as stated in the public announcement of the extension). See
Section 4 below. |
Is there any cost to tender?
| |
• |
|
There is no cost charged by us in connection with this Offer. See the Letter of Transmittal.
|
May I withdraw my Shares after I have tendered them and, if so, by when?
| |
• |
|
Yes, you may withdraw your Shares at any time prior to the expiration of the Offer (including any extension
period) by submitting a Notice of Withdrawal to us at the address listed on page 10, which must be received by us prior to the expiration of the Offer (including any extension period). In addition, you may withdraw your tendered Shares any time
after April 25, 2023 (which is forty (40) business days after the commencement of the Offer), if they have not been accepted for payment by that date. See Section 5 below. |
How do I withdraw tendered Shares?
| |
• |
|
A Notice of Withdrawal of tendered Shares, which specifies the name of the shareholder who tendered the Shares,
the number of Shares being withdrawn and other information, must be received by us prior to the expiration of the Offer (including any extension period). See Section 5 below and the Form of Notice of Withdrawal which accompanies this Offer as
Exhibit 99(a)(1)(D). |
May I place any conditions on my tender of Shares?
Is there a limit on the number of Shares I may tender?
What if more than the amount of Shares offered for repurchase are tendered (and not timely withdrawn)?
| |
• |
|
We may, in our sole discretion, either accept the additional duly tendered Shares permitted to be accepted
pursuant to Rule 13e-4(f)(1)(ii) under the Exchange Act, or repurchase Shares from tendering shareholders on a pro rata basis in accordance with the number of Shares tendered by each shareholder (and
not timely withdrawn). |
If I decide not to tender, how will the Offer affect the Shares I hold?
| |
• |
|
If Shares are tendered pursuant to the Offer, your percentage ownership interest in the Company will increase
after completion of the Offer. If no Shares are tendered pursuant to the Offer, your percentage ownership in the Company will not be affected as a result of the Offer. See Section 10 below. |
Does the Company have the financial resources to make payment for Shares tendered in the Offer?
| |
• |
|
Yes. See Section 7 below. |
If the Company accepts the Shares I tender, when will payment be made?
| |
• |
|
Payment for properly tendered Shares (which are not timely withdrawn) will be made promptly following expiration
of the Offer. See Section 6 below. |
What is the accounting treatment of the Offer?
| |
• |
|
The purchase of Shares pursuant to the Offer will result in a reduction of our shareholders’ equity in an
amount equal to the aggregate Purchase Price of the Shares we purchase and a corresponding increase in liabilities and/or reduction in total cash and cash equivalents depending on the source of funding. See Section 10 below.
|
Is my sale of Shares in the Offer a taxable transaction?
| |
• |
|
For most shareholders, yes. We anticipate that U.S. Shareholders (defined in Section 13 below), other than
those who are tax-exempt, who sell Shares in the Offer will recognize gain or loss for U.S. federal income tax purposes equal to the difference between the cash they receive for the Shares sold and their
adjusted tax basis in the Shares. The sale date for tax purposes will be the date we accept Shares for purchase. See Section 13 below for details, including the nature of the income or loss and the possibility of other tax treatment.
Section 13 also discusses the treatment of Non-U.S. Shareholders. Please consult your tax advisor for details regarding your specific tax treatment and obligations. |
Is the Company required to complete the Offer and purchase all Shares tendered, assuming the total Shares tendered are less than the total Shares offered?
| |
• |
|
Under most circumstances, yes. There are certain circumstances, however, in which we will not be required to
purchase any Shares tendered, as described in Section 3 below. |
Is there any reason Shares tendered would not be accepted?
| |
• |
|
In addition to those circumstances described in Section 3 in which the Company is not required to accept
tendered Shares, we have reserved the right to reject any and all tenders determined by us not to be in appropriate form, subject to the rights of tendering shareholders to challenge the Company’s determination in a court of competent
jurisdiction. For example, tenders will be rejected if the tender does not include original signature(s) or the original of any required signature guarantee(s). |
How will tendered Shares be accepted for payment?
| |
• |
|
Properly tendered Shares will be accepted for payment promptly following expiration of the Offer. See
Section 6 below. |
Do I need to take any action if I decide not to tender my Shares?
Does management encourage shareholders to participate in the Offer, and will they participate in the Offer?
| |
• |
|
No. Neither we nor our Board nor the Adviser is making any recommendation to tender or to not tender Shares in
the Offer. No other person has been authorized to make any recommendation on behalf of the Company, our Board or the Adviser as to whether shareholders should tender or refrain from tendering Shares pursuant to this offer, or to make any
representation or give any information in connection with this Offer other than that which is contained herein or in the accompanying Letter of Transmittal. If made or given, any such recommendation must not be relied upon as having been authorized
by the Company, our Board or the Adviser. Shareholders should consult their own investment and tax advisers and make their own decisions regarding whether to tender or refrain from tendering their Shares. None of our directors or executive officers
and none of the Adviser’s executive officers will tender any of their Shares in the Offer. See Section 1 below. |
How do I
obtain information?
| |
• |
|
Questions and requests for assistance or requests for additional copies of the Offer to Purchase, the Letter of
Transmittal and all other Offer documents should be directed to Owl Rock Capital Corporation II as follows: |
|
|
|
| Telephone: |
|
(844) 331-3341 |
|
|
| If using UPS, FedEx or Courier: |
|
If using a USPS Service: |
|
|
| Owl Rock Capital Corporation II c/o DST
Systems, Inc. as Processing Agent STE 219398 430 W 7th Kansas
City, Mo. 64105-1407 |
|
Owl Rock Capital Corporation II c/o DST
Systems, Inc. as Processing Agent P.O. Box 219398 Kansas
City, Mo. 64121-9398 |
The Letter of Transmittal should be sent to the Company at the following address:
|
|
|
| If using UPS, FedEx or Courier: |
|
If using a USPS Service: |
|
|
| Owl Rock Capital Corporation II
c/o DST Systems, Inc. as Processing Agent
STE 219398 430 W 7th
Kansas City, Mo. 64105-1407 |
|
Owl Rock Capital Corporation II
c/o DST Systems, Inc. as Processing Agent
P.O. Box 219398
Kansas City, Mo. 64121-9398 |
If by email: OwlRock.tender@dstsystems.com
TABLE OF CONTENTS
|
|
|
|
|
| Section |
|
Page |
|
| 1. Purchase Price; Number of Shares; Expiration Date. |
|
|
1 |
|
| 2. Purpose of the Offer; Plans or Proposals of the Company. |
|
|
2 |
|
| 3. Certain Conditions of the Offer. |
|
|
2 |
|
| 4. Procedures for Tendering Shares. |
|
|
3 |
|
| 5. Withdrawal Rights. |
|
|
4 |
|
| 6. Payment for Shares. |
|
|
5 |
|
| 7. Source and Amount of Funds. |
|
|
5 |
|
| 8. Financial Statements. |
|
|
5 |
|
| 9. Interest of Directors, Executive Officers and Certain Related Persons;
Transactions and Arrangements Concerning the Shares. |
|
|
5 |
|
| 10. Certain Effects of the Offer. |
|
|
6 |
|
| 11. Certain Information about the Company. |
|
|
7 |
|
| 12. Additional Information. |
|
|
7 |
|
| 13. Certain United States Federal Income Tax Consequences. |
|
|
8 |
|
| 14. Amendments; Extension of Tender Period; Termination. |
|
|
10 |
|
| 15. Forward Looking Statements; Miscellaneous. |
|
|
10 |
|
1. Purchase Price; Number of Shares; Expiration Date.
Owl Rock Capital Corporation II, an externally managed closed-end management investment company that has elected to be
regulated as a business development company under the 1940 Act, and that is incorporated in Maryland is offering to purchase up to the number of Shares that can be repurchased with $10,000,000. The purpose of the Offer is to provide shareholders
with the potential for a measure of liquidity since there is otherwise no public market for our Common Stock. See Section 2 below. The Offer is for cash at a price per share equal to the Purchase Price. You will not receive interest on the
Purchase Price under any circumstances.
If more than the number of Shares offered for repurchase are duly tendered pursuant to the Offer (and not
withdrawn, as provided in Section 5 below), we may, in our sole discretion, either accept the additional tendered Shares permitted to be accepted pursuant to Rule 13e-4(f)(1)(ii) under the Exchange Act,
or repurchase Shares on a pro rata basis, in accordance with the number of Shares duly tendered by or on behalf of each shareholder (and not so withdrawn). As a result, we may repurchase less than the full amount of Shares that you request to
have repurchased.
As of February 20, 2023, there were approximately 147,010,771 shares of our Common Stock issued and outstanding.
The Offer will remain open until 11:59 P.M., Eastern Time, on March 27, 2023 (the “Expiration Date”), unless and until we, in our
discretion, extend the period of time during which the Offer will remain open. If we extend the period of time during which the Offer remains open, the term “Expiration Date” will refer to the latest time and date at which the Offer
expires. See Section 14 below for a description of our rights to extend, delay, terminate and/or amend the Offer.
If we materially change the terms
of the Offer or the information concerning the Offer, or if we waive a material condition of the Offer, we will extend the Offer to the extent required by Rules 13e-4(d)(2) and
13e-4(e)(3) promulgated under the Exchange Act. These rules require that the minimum period during which an offer must remain open following material changes in the terms of the offer or information concerning
the offer (other than a change in price or a change in percentage of securities sought) will depend on the facts and circumstances, including the relative materiality of such terms or information. If (i) we increase or decrease the price to be
paid for Shares, or we increase or decrease the number of Shares being sought and (ii) the Offer is scheduled to expire at any time earlier than the expiration of a period ending on the tenth (10th) business day from, and including, the date
that notice of such increase or decrease is first published, sent or given, the Offer will be extended at least until the expiration of such period of ten (10) business days. In addition, to the extent the methodology by which we determine the
Purchase Price changes following the date tender offer materials were provided to you, we will extend the Offer by at least ten (10) business days.
A “business day” means any day other than a Saturday, Sunday or federal holiday and consists of the time period from 12:01 A.M. through 12:00
midnight, Eastern Time.
In the judgment of our Board, including the independent directors, the Offer is in the best interests of our shareholders and
does not violate applicable law. Under the Maryland General Corporation Law, a Maryland corporation may not make a distribution to shareholders, including pursuant to a repurchase program, if, after giving effect to the distribution, (i) the
corporation would not be able to pay its indebtedness in the ordinary course or (ii) the corporation’s total assets would be less than its total liabilities plus preferential amounts payable on dissolution with respect to preferred stock.
The Board may also consider the following factors, among others, in making its determination regarding whether to cause us to offer to repurchase Shares
and under what terms:
| |
• |
|
the effect of such repurchases on our intended qualification as a regulated investment company
(“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”) (including the consequences of any necessary asset sales); |
| |
• |
|
the liquidity of our assets (including fees and costs associated with disposing of assets);
|
| |
• |
|
our investment plans and working capital requirements; |
| |
• |
|
the relative economies of scale with respect to our size; |
1
| |
• |
|
our history in repurchasing Shares or portions thereof; and |
| |
• |
|
the condition of the securities markets. |
The Board has approved this Offer. The Board recognizes that the decision to accept or reject the Offer is an individual one that should be based on a variety
of factors, and shareholders should consult with their personal advisors if they have questions about their specific financial or tax situation. As a result, neither we, our Board nor our Adviser are expressing any opinion as to whether a
shareholder should accept or reject this Offer. No other person has been authorized to make any recommendation on our, our Board’s or the Adviser’s behalves as to whether shareholders should tender or refrain from tendering Shares pursuant
to this offer, or to make any representation or give any information in connection with this Offer other than that which is contained herein or in the accompanying Letter of Transmittal. If made or given, any such recommendation must not be relied
upon as having been authorized by us, our Board or the Adviser.
2. Purpose of the Offer; Plans or Proposals of the Company.
The purpose of the Offer is to provide our shareholders with the potential for a measure of liquidity since there is otherwise no market for our Common Stock.
We will conduct this repurchase offer to allow shareholders to tender their shares of our Common Stock at the price at which we issue Shares pursuant to
our distribution reinvestment plan, which is expected to reflect a recently calculated net asset value per Share. This Offer is being made at the discretion of the Board and subject to applicable law, including Section 23(c) of the 1940 Act and
Rule 13e-4 under the Exchange Act. Subject to the Board’s discretion, we intend to conduct quarterly tender offers in accordance with the requirements of Rule 13e-4
under the Exchange Act and the 1940 Act. The Board has complete discretion to determine whether we will engage in any share repurchase and, if so the terms of such repurchase. At the discretion of the Board, we may use cash on hand, cash available
from borrowings, and cash from liquidation of securities investments as of the end of the applicable period to repurchase Shares.
Except as previously
disclosed by us, or as may occur in the ordinary course of business, we do not have any present plans or proposals and are not engaged in any negotiations that relate to or would result in: (a) any extraordinary transaction, such as a merger,
reorganization or liquidation, involving the Company or any of its subsidiaries; (b) other than in connection with transactions in the ordinary course of the Company’s operations and for purposes of funding the Offer, any purchase, sale or
transfer of a material amount of assets of the Company or any of its subsidiaries; (c) any material change in the Company’s present dividend rate or policy, or indebtedness or capitalization of the Company; (d) any change in the
composition of the Board or management of the Company, including, but not limited to, any plans or proposals to change the number or the term of members of the Board, to fill any existing vacancies on the Board or to change any material term of the
employment contract of any executive officer; (e) any other material change in the Company’s corporate structure or business, including any plans or proposals to make any changes in the Company’s investment policy for which a vote
would be required by Section 13 of the 1940 Act; (f) any class of the Company’s equity securities being delisted from a national securities exchange or ceasing to be authorized to be quoted in an automated quotations system operated
by a registered national securities association; (g) any class of the Company’s equity securities becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; (h) the suspension of the
Company’s obligation to file reports pursuant to Section 15(d) of the Exchange Act; (i) other than in connection with transactions in the ordinary course of the Company’s operations, any changes in the Company’s charter,
bylaws or other governing instruments or other actions that could impede the acquisition of control of the Company.
3. Certain Conditions of the
Offer.
Shares held of record as of February 20, 2023 are eligible to be repurchased pursuant to the Offer. If the amount of repurchase
requests exceeds the number of Shares we seek to repurchase, we may, in our sole discretion, either accept the additional duly tendered Shares permitted to be accepted pursuant to Rule 13e-4(f)(1)(ii) under
the Exchange Act, or repurchase Shares on a pro rata basis in accordance with the number of Shares tendered by each shareholder (and not timely withdrawn).
2
Notwithstanding any other provision of the Offer, we will not be required to purchase any Shares tendered
pursuant to the Offer if such repurchase will cause us to be in violation of the securities, commodities or other laws of the United States or any other relevant jurisdiction. Further, we will not be required to purchase any Shares tendered in the
Offer if there is any (i) material legal action or proceeding instituted or threatened which challenges, in the Board’s judgment, the Offer, or otherwise materially adversely affects the Company or the value of our Common Stock,
(ii) declaration of a banking moratorium by Federal, state or foreign authorities or any suspension of payment by banks in the United States, New York State or in a foreign country that is material to the Company, (iii) limitation that
affects the Company or the issuers of its portfolio securities imposed by Federal, state or foreign authorities on the extension of credit by lending institutions or on the exchange of foreign currencies, (iv) commencement of war, armed
hostilities or other international or national calamity directly or indirectly involving the United States or any foreign country that is material to the Company, or (v) other event or condition which, in the Board’s judgment, would have a
material adverse effect on the Company or its shareholders if Shares tendered pursuant to the Offer were purchased.
The foregoing conditions are for our
sole benefit and may be asserted by us regardless of the circumstances giving rise to any such condition, and any such condition may be waived by us, in whole or in part, at any time and from time to time in our reasonable judgment. Our failure at
any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right; the waiver of any such right with respect to particular facts and circumstances shall not be deemed a waiver with respect to any other facts or
circumstances; and each such right shall be deemed an ongoing right which may be asserted at any time and from time to time; provided that any such waiver shall apply to all tenders of Shares. Any determination by us concerning the events described
in this Section 3 shall be final and binding, subject to the rights of tendering shareholders to challenge our determination in a court of competent jurisdiction.
We reserve the right, at any time during the pendency of the Offer, to amend, extend or terminate the Offer in any respect. See Section 14 below.
4. Procedures for Tendering Shares.
Participation
in the Offer is voluntary. If you elect not to participate in the Offer, your Shares will remain outstanding. To participate in the Offer, you must complete and deliver the accompanying Letter of Transmittal to us at:
|
|
|
| If using UPS, FedEx or Courier: |
|
If using a USPS Service: |
|
|
| Owl Rock Capital Corporation II |
|
Owl Rock Capital Corporation II |
| c/o DST Systems, Inc. as Processing Agent |
|
c/o DST Systems, Inc. as Processing Agent |
| STE 219398 430 W 7th |
|
P.O. Box 219398 |
| Kansas City, Mo. 64105-1407 |
|
Kansas City, Mo. 64121-9398 |
If by email: OwlRock.tender@dstsystems.com
The Letter of Transmittal must be received by us at the address above before 11:59 P.M., Eastern Time, on March 27, 2023, when the Offer expires.
a. Proper Tender of Shares and Method of Delivery. For Shares to be properly tendered pursuant to the Offer, a properly completed and duly executed
Letter of Transmittal bearing original signature(s) and the originals of any required signature guarantee(s) for all Shares to be tendered and any other documents required by the Letter of Transmittal must be physically received by us at the address
listed above before 11:59 P.M., Eastern Time, on the Expiration Date. These materials may be sent via mail, courier, or personal delivery.
THE METHOD
OF DELIVERY OF THE LETTER OF TRANSMITTAL AND ANY OTHER REQUIRED DOCUMENTS IS AT THE OPTION AND SOLE RISK OF THE TENDERING SHAREHOLDER. IF DOCUMENTS ARE SENT BY MAIL, REGISTERED MAIL WITH RETURN RECEIPT REQUESTED AND PROPERLY INSURED, IS RECOMMENDED.
3
Shareholders have the responsibility to cause their Shares to be tendered, the Letter of Transmittal properly
completed and bearing original signature(s), including any required signature guarantees, and any other documents required by the Letter of Transmittal, to be timely delivered. Timely delivery is a condition precedent to acceptance of Shares for
purchase pursuant to the Offer and to payment of the Purchase Price.
b. Determination of Validity. All questions as to the validity, form,
eligibility (including time of receipt), and acceptance of tenders will be determined by us, in our sole discretion, which determination shall be final and binding, subject to the rights of tendering shareholders to challenge our determination in a
court of competent jurisdiction. We reserve the absolute right to reject any or all tenders determined not to be in appropriate form or to refuse to accept for payment, purchase, or pay for, any Shares if, in the opinion of our counsel, accepting,
purchasing or paying for such Shares would be unlawful. We also reserve the absolute right to waive any of the conditions of the Offer or any defect in any tender, whether generally or with respect to any particular Share(s) or shareholder(s). Our
interpretations, in consultation with our counsel, of the terms and conditions of the Offer shall be final and binding, subject to the rights of tendering shareholders to challenge our determination in a court of competent jurisdiction.
NEITHER THE COMPANY, NOR ITS BOARD, NOR THE ADVISER NOR ANY OTHER PERSON IS OR WILL BE OBLIGATED TO GIVE ANY NOTICE OF ANY DEFECT OR IRREGULARITY IN ANY
TENDER, AND NONE OF THEM WILL INCUR ANY LIABILITY FOR FAILURE TO GIVE ANY SUCH NOTICE.
c. United States Federal Income Tax Withholding. To
prevent the imposition of U.S. federal backup withholding tax equal to 24% of the gross payments made pursuant to the Offer, prior to receiving such payments, each shareholder accepting the Offer who has not previously submitted to the Company a
correct, completed, and signed Internal Revenue Service (“IRS”) Form W-9 (“Form W-9”) (for U.S. Shareholders) or IRS Form
W-8BEN (“Form W-8BEN”), IRS Form W-8IMY (“Form
W-8IMY”), IRS Form W-8ECI (“Form W-8ECI”), or other applicable form (for Non-U.S. Shareholders), or otherwise established an exemption from such withholding, must submit the appropriate form to the Company. See Section 13 below.
For this purpose, a “U.S. Shareholder” is, in general, a shareholder that is (i) a citizen or resident of the United States, (ii) a
corporation, partnership or other entity created or organized in or under the laws of the United States or any political subdivision thereof, (iii) an estate the income of which is subject to United States federal income taxation regardless of
the source of such income or (iv) a trust if (A) a court within the United States is able to exercise primary supervision over the administration of the trust and (B) one or more U.S. persons have the authority to control all
substantial decisions of the trust. A “Non-U.S. Shareholder” is any shareholder other than a U.S. Shareholder.
5. Withdrawal Rights.
At any time prior to 11:59
P.M., Eastern Time, on the Expiration Date, and, if the Shares have not by then been accepted for payment by us, at any time after April 25, 2023 (which is forty (40) business days after the commencement of the Offer), any shareholder may
withdraw any amount of the Shares that the shareholder has tendered. To be effective, a written notice of withdrawal of Shares tendered must be timely received by us via mail, courier, or personal delivery at the address listed on page 10. Any
notice of withdrawal must be substantially in the form attached hereto as Exhibit 99(a)(1)(D) and specify the name(s) of the person having tendered the Shares to be withdrawn and the number of Shares to be withdrawn.
All questions as to the validity, form and eligibility (including time of receipt) of notices of withdrawal will be determined by us in our sole discretion,
which determination shall be final and binding, subject to the rights of tendering shareholders to challenge our determination in a court of competent jurisdiction. Shares properly withdrawn will not thereafter be deemed to be tendered for purposes
of the Offer. Withdrawn Shares, however, may be re-tendered by following the procedures described in Section 4 above prior to 11:59 P.M., Eastern Time, on the Expiration Date.
4
6. Payment for Shares.
Our acceptance of your Shares will form a binding agreement between you and the Company on the terms and subject to the conditions of this Offer. You will not
receive interest on the Purchase Price under any circumstances.
In all cases, payment for Shares purchased pursuant to the Offer will be made only after
timely receipt by us of: (a) a Letter of Transmittal properly completed and bearing original signature(s) and any required signature guarantee(s), and (b) any other documents required by the Letter of Transmittal. We may not be obligated
to purchase Shares pursuant to the Offer under certain conditions. See Section 3 above.
Any tendering shareholder or other payee who has not
previously submitted a correct, completed, and signed Form W-9, Form W-8BEN, Form W-8IMY, Form
W-8ECI or other appropriate form, as necessary, and who fails to complete fully and sign either the Substitute Form W-9 in the Letter of Transmittal or other appropriate
form (e.g., Form W-8BEN, Form W-8IMY or Form W-8ECI) and provide such properly completed form to us may be subject to federal
backup withholding tax of 24% of the gross proceeds paid to such shareholder or other payee pursuant to the Offer. See Section 13 regarding this tax as well as possible withholding at the rate of 30% (or lower applicable treaty rate) on certain
amounts payable to tendering Non-U.S. Shareholders.
7. Source and Amount of Funds.
The total maximum cost to us for repurchasing Shares pursuant to the Offer would be $10,000,000, excluding filing, printing, mailing, and processing fees. As
discussed in Section 1, we are limiting the aggregate number of Shares to be repurchased to the amount of Shares that can be repurchased with $10,000,000. The actual number of Shares that will be repurchased and our total cost of purchasing
Shares pursuant to the Offer is not determinable at this time.
We will use cash on hand to fund the purchase of Shares validly tendered and not withdrawn
in the Offer.
8. Financial Statements.
Financial statements have not been included herein because the consideration offered to shareholders consists solely of cash; the Offer is not subject to any
financing condition; and the Company is a public reporting company under Section 13(a) of the Exchange Act, and files its reports electronically on the EDGAR system.
Reports and other information about the Company are available on the EDGAR Database on the SEC’s Internet site (www.sec.gov), and copies of this
information may be obtained, after paying a duplicating fee, by electronic request at the following E-mail address: publicinfo@sec.gov.
9. Interest of Directors, Executive Officers and Certain Related Persons; Transactions and Arrangements Concerning the Shares.
Shares Outstanding. As of February 20, 2023, we had 147,010,771 issued and outstanding Shares.
Interests of Directors and Executive Officers. As of February 20, 2023, our directors and executive officers as a group (14 persons) beneficially
owned an aggregate of 130,556 Shares, representing less than 1% of the total number of outstanding Shares. None of our directors or executive officers intends to tender any of their Shares in the Offer.
The following tables set forth, based on a total of 147,010,771 shares issued and outstanding as of February 20, 2023, (1) the aggregate number of Shares
that were beneficially owned (as determined under Rule 13d-3 promulgated under the Exchange Act) by each of our current directors and executive officers, and by all directors and executive officers as a group,
as of February 20, 2023, and (2) the aggregate number and percentage of Shares that were beneficially owned (as determined under Rule 13d-3 promulgated under the Exchange Act) by each person who owns
(to our knowledge and based on the most current Schedule 13Ds and 13Gs filed with the SEC for each such person) more than five percent (5%) of the outstanding Shares. For purposes of these tables, and in accordance with the rules promulgated by the
SEC, Shares are considered “beneficially owned” if the person directly or indirectly has sole or shared power to vote or direct the voting of the securities or has sole or shared power to divest
5
of or direct the divestment of the securities. A person is also considered to beneficially own Shares that he or
she has the right to acquire within sixty (60) days after February 20, 2023, in accordance with Rule 13d-3 promulgated under the Exchange Act. Except as indicated, each holder has sole voting and
dispositive power over the listed Shares.
Summary of Ownership by Executive Officers and Directors:
|
|
|
|
|
|
|
|
|
| Name and Address |
|
Number
of
Shares
Owned |
|
|
Percentage
of
class
outstanding
(as of
February 20,
2023) |
|
| Interested Directors |
|
|
|
|
|
|
|
|
| Craig Packer |
|
|
116,667 |
|
|
|
* |
|
| Independent Directors(1) |
|
|
|
|
|
|
|
|
| Edward D’Alelio |
|
|
None |
|
|
|
0 |
% |
| Christopher Temple |
|
|
None |
|
|
|
0 |
% |
| Eric Kaye |
|
|
None |
|
|
|
0 |
% |
| Melissa Weiler |
|
|
None |
|
|
|
0 |
% |
| Victor Woolridge |
|
|
None |
|
|
|
0 |
% |
| Executive Officers(1) |
|
|
|
|
|
|
|
|
| Karen Hager |
|
|
None |
|
|
|
0 |
% |
| Bryan Cole |
|
|
None |
|
|
|
0 |
% |
| Alan Kirshenbaum |
|
|
13,889 |
|
|
|
* |
|
| Jonathan Lamm |
|
|
None |
|
|
|
0 |
% |
| Neena Reddy |
|
|
None |
|
|
|
0 |
% |
| Matthew Swatt |
|
|
None |
|
|
|
0 |
% |
| Shari Withem |
|
|
None |
|
|
|
0 |
% |
| Jennifer McMillon |
|
|
None |
|
|
|
0 |
% |
| All officers and directors as a group (14 persons) |
|
|
130,556 |
|
|
|
* |
|
| (1) |
The address for all of the Company’s officers and directors is c/o Owl Rock Capital Advisors LLC, 399 Park
Avenue, New York, NY 10022. |
Except for shares purchased under our DRIP, and based upon our records and upon information provided to us,
there have not been any other transactions in shares that as of February 20, 2023 were effected during such period by any of our directors or executive officers, any person controlling the Company, any director or executive officer of any
corporation or other person ultimately in control of the Company, any associate or minority-owned subsidiary of the Company or any executive officer or director of any subsidiary of the Company. Except as set forth in this Offer, neither we nor, to
the best of our knowledge, any of the above mentioned persons, is a party to any contract, arrangement, understanding or relationship with any other person relating, directly or indirectly, to the Offer with respect to any of our securities
(including, but not limited to, any contract, arrangement, understanding or relationship concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guaranties of loans, guaranties
against loss or the giving or withholding of proxies, consents or authorizations). Based upon information provided or available to us, none of our directors or executive officers intends to tender Shares pursuant to the Offer. The Offer does not,
however, restrict the purchase of Shares pursuant to the Offer from any such person.
10. Certain Effects of the Offer.
The purchase of Shares pursuant to the Offer may have the effect of increasing the proportionate interest in the Company of shareholders who do not tender
Shares. If Shares are purchased pursuant to the Offer, all shareholders remaining after the Offer will be subject to any increased risks associated with the reduction in the number of outstanding shares of our Common Stock and the reduction in the
Company’s assets resulting from payment for the tendered Shares. See Section 7 above. All Shares purchased by the Company pursuant to the Offer will be retired and thereafter will be authorized and unissued shares. Rule 13e-4 promulgated under the Exchange Act prohibits us and our affiliates from purchasing any Shares, other than pursuant to the Offer, until at least ten (10) business days following the Expiration Date.
6
Accounting Treatment. The purchase of Shares pursuant to the Offer will result in a reduction of our
shareholders’ equity in an amount equal to the aggregate Purchase Price of the Shares we purchase and a corresponding increase in liabilities and/or reduction in total cash and cash equivalents depending on the source of funding.
11. Certain Information about the Company.
We are
an externally managed closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. We have elected to be treated for federal income tax
purposes as a RIC under Subchapter M of the Code. We are managed by the Adviser, a Delaware limited liability company that is registered as an investment adviser with the SEC. The Adviser oversees the management of our activities and is responsible
for making investment decisions for our portfolio.
Our investment objective is to generate current income and, to a lesser extent, capital appreciation
by targeting investment opportunities with favorable risk-adjusted returns. Our investment strategy focuses primarily on originating and making loans to, and making debt and equity investments in, U.S. middle market companies. We invest in senior
secured or unsecured loans, subordinated loans or mezzanine loans and, to a lesser extent, equity and equity-related securities which include common and preferred stock, securities convertible into common stock, and warrants. We define “middle
market companies” to generally mean companies with earnings before interest expense, income tax expense, depreciation and amortization (“EBITDA”) between $10 million and $250 million annually, and/or annual revenue of
$50 million to $2.5 billion at the time of investment. We may on occasion invest in smaller or larger companies if an attractive opportunity presents itself, especially when there are dislocations in the capital markets, including the high
yield and large syndicated loan markets. We generally invest in companies with a low loan-to-value ratio, which we consider to be 50% of below. Our target credit
investments will typically have maturities between three and ten years and generally range in size between $10 million and $125 million, although the investment size will vary with the size of our capital base.
Our principal office is located at 399 Park Avenue, New York, New York 10022.
12. Additional Information.
Information
concerning our business, including our background, strategy, business, investment portfolio, competition, and personnel, as well as our financial information, is included in:
| |
• |
|
our Registration Statement on Form N-2 filed with the SEC on
June 26, 2020, and as amended and supplemented thereafter; |
| |
• |
|
our Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, as filed with the SEC on March 4, 2022; |
| |
• |
|
our Quarterly Reports on Form 10-Q for the quarters ended March 31,
2022, June 30, 2022 and September 30, 2022, as filed with the SEC on May 11, 2022, August 10, 2022 and November 9, 2022, respectively; |
| |
• |
|
our Current Reports on Form 8-K (excluding any information furnished
therein), as filed with the SEC on January 3, 2022, January 26, 2022, January 27, 2022, March 28, 2022, March 30, 2022, May 10, 2022, May 31, 2022, June 30, 2022, July 5, 2022, September 2, 2022,
September 30, 2022, December 1, 2022, January 3, 2023 and February 3, 2023; |
| |
• |
|
our Annual Proxy Statement, as filed with the SEC on April 11, 2022; and |
| |
• |
|
our Issuer Tender Offer Statement on Schedule TO, as filed with the SEC on February 21, 2023.
|
Each of the foregoing documents is incorporated by reference herein. We also hereby incorporate by reference additional documents that
we may file with the SEC between the date of this Offer and the Expiration Date of this Offer. The SEC maintains an Internet site that contains reports, proxy and information statements and other information filed electronically by us with the SEC,
which are available on the SEC’s website at http://www.sec.gov. Copies of these reports, proxy and information statements and other information may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov.
7
We are not aware of any license or regulatory permit that is material to our business that might be adversely
affected by our acquisition of Shares as contemplated pursuant to the Offer, nor are we aware of any approval or other action by any government or governmental, administrative or regulatory authority, agency or body, domestic, foreign or
supranational, that would be required for our acquisition or ownership of Shares as contemplated by the Offer. Should any such approval or other action or notice filings be required, we presently contemplate that we will seek that approval or other
action and make or cause to be made such notice filings. We cannot predict whether we will be required to delay the acceptance for payment of or payment for Shares tendered in the Offer pending the outcome of any such approval or other action. There
can be no assurance that any such approval or other action, if needed, would be obtained or would be obtained without substantial cost or conditions or that the failure to obtain the approval or other action might not result in adverse consequences
to our business and financial condition. Our obligations pursuant to the Offer to accept for payment and pay for Shares are subject to the satisfaction of certain conditions. See Section 3.
13. Certain United States Federal Income Tax Consequences.
The following is a summary of the material U.S. federal income tax consequences of the Offer to U.S. Holders and
Non-U.S. Holders (each as defined below), in each case, whose Shares are tendered and accepted for payment pursuant to the Offer. This summary is based upon the Code, U.S. Treasury Regulations promulgated
under the Code, published rulings, administrative pronouncements and judicial decisions, any changes to which could affect the tax consequences described in this Offer (possibly on a retroactive basis). This summary assumes that Shares held by
shareholders as capital assets within the meaning of section 1221 of the Code (generally, property held for investment). It does not address all of the tax consequences that may be relevant to particular shareholders in light of their particular
circumstances, or to shareholders subject to special rules, including, without limitation, pass-through entities (including arrangements and entities treated as partnerships, “grantor trusts” and S corporations for U.S. federal income tax
purposes) and investors in such entities, certain financial institutions, brokers, dealers or traders in securities or commodities, insurance companies, U.S. expatriates, mutual funds, real estate investment trusts, BDCs, cooperatives, trusts and
estates, persons who mark-to-market our Shares, tax-exempt organizations, persons who are subject to the alternative minimum tax,
persons who hold Shares as a position in a “straddle” or as part of a “hedging” or “conversion” transaction or other integrated investment, shareholders that have a functional currency other than the U.S. dollar, or
persons who acquired their Shares upon the exercise of stock options or otherwise as compensation. This summary also does not address any state, local, non-U.S. or other tax consequences of participating in
the Offer. See Section 4.c. “Procedures for Tendering Shares—United States Federal Income Tax Withholding” above. This summary is included for general information only. Each Shareholder is urged to consult such
Shareholder’s own tax advisor to determine the particular tax consequences to him or her of the Offer, including the applicability and effect of state, local and foreign tax laws.
For purposes of this discussion, a “U.S. Holder” is a beneficial holder of Shares that, for U.S. federal income tax purposes, is (1) a citizen
or individual resident of the United States, (2) a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, that is created or organized in or under the laws of the United States or any State or the District
of Columbia, (3) an estate, the income of which is subject to U.S. federal income taxation regardless of its source, or (4) a trust if (x) a U.S. court is able to exercise primary supervision over its administration and one or more
U.S. persons, within the meaning of section 7701(a)(30) of the Code, have authority to control all of its substantial decisions, or (y) it has a valid election in place to be treated as a U.S. person.
A “Non-U.S. Holder” is a beneficial holder of Shares that is not a “pass-through entity”
(including a partnership) for U.S. federal income tax purposes and that also is not a U.S. Holder.
a. U.S. Shareholders. The sale of Shares
pursuant to the Offer generally will be a taxable transaction for federal income tax purposes, either as a “sale or exchange,” or under certain circumstances, as a “dividend.” Under Section 302(b) of the Code, a sale of
Shares pursuant to the Offer generally will be treated as a “sale or exchange” if the receipt of cash: (a) results in a “complete termination” of the shareholder’s interest in the Company, (b) is
“substantially disproportionate” with respect to the shareholder or (c) is “not essentially equivalent to a dividend” with respect to the shareholder. In determining whether any of these tests has been met, Shares actually
owned, as
8
well as Shares considered to be owned by the shareholder by reason of certain constructive ownership rules set forth in Section 318 of the Code, generally must be taken into account.
Although it generally is anticipated that most shareholders who tender shares would satisfy one of these three tests for “sale or exchange” treatment, shareholders should consult their own tax advisors to determine if any of these tests
would be satisfied in light of their own unique circumstances. If any of these three tests for “sale or exchange” treatment is met, a shareholder will recognize gain or loss equal to the difference between the amount of cash received
pursuant to the Offer and the adjusted tax basis of the Shares sold. The gain or loss will be a capital gain or loss. In general, capital gain or loss with respect to Shares sold will be long-term capital gain or loss if the holding period for such
Shares is more than one year. The maximum long-term capital gains rate applicable to individual shareholders is generally 15% or 20%, depending on whether the individual’s income exceeds certain thresholds. Specific limitations may apply to the
deductibility of capital losses by a U.S. holder. Under the “wash sale” rules of the Code, recognition of a loss on Shares sold pursuant to the Offer ordinarily will be disallowed to the extent a shareholder acquires substantially
identical Shares within 30 days before or after the date the Shares are purchased by the Company pursuant to the Offer. In that event, the basis and holding period of the Shares acquired will be adjusted to reflect the disallowed loss. Additionally,
any loss realized upon a taxable disposition of Shares held for six months or less will be treated as a long-term capital loss to the extent of any capital gains dividends received by the shareholder (or amounts credited to the shareholder as
undistributed capital gains) with respect to such Shares.
If none of the tests set forth in Section 302(b) of the Code are met, amounts received by
a shareholder who sells Shares pursuant to the Offer will be taxable to the shareholder as a “dividend” to the extent of such shareholder’s allocable share of the Company’s current or accumulated earnings and profits. The excess
of such amounts received over the portion that is taxable as a dividend will constitute a non-taxable return of capital (to the extent of the shareholder’s tax basis in the Shares sold pursuant to the
Offer). Any amounts received in excess of the shareholder’s tax basis in such case will be treated as taxable gain. If the amounts received by a tendering Shareholder are treated as a “dividend,” the tax basis in the Shares tendered
to the Company will be transferred to any remaining Shares held by such shareholder.
In addition, if a tender of Shares is treated as a
“dividend” to a tendering shareholder, the IRS may take the position that a constructive distribution under Section 305(c) of the Code may result to a shareholder whose proportionate interest in the earnings and assets of the Company
has been increased by such tender. Shareholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the sale of Shares pursuant to the Offer.
Individuals with modified adjusted gross incomes in excess of $200,000 ($250,000 in the case of married individuals filing jointly) and certain estates and
trusts are subject to an additional 3.8% tax on their “net investment income,” which generally includes net income from interest, dividends, annuities, royalties, and rents, and net capital gains (other than certain amounts earned from
trades or businesses).
The Company may be required to withhold 24% of the gross proceeds paid to a U.S. Shareholder or other payee pursuant to the Offer
unless either: (a) the U.S. Shareholder has completed and submitted to the Company a Form W-9 (or Substitute Form W-9), providing the U.S. Shareholder’s
employer identification number or social security number as applicable, and certifying under penalties of perjury that: (1) such number is correct; (2) either (i) the U.S. Shareholder is exempt from backup withholding, (ii) the U.S.
Shareholder has not been notified by the IRS that the U.S. Shareholder is subject to backup withholding as a result of an under-reporting of interest or dividends, or (iii) the IRS has notified the U.S. Shareholder that the U.S. Shareholder is
no longer subject to backup withholding; or (b) an exception applies under applicable law. A Substitute Form W-9 is included as part of the Letter of Transmittal for U.S. Shareholders.
b. Non-U.S. Shareholders. The U.S. federal income taxation of a Non-U.S.
Shareholder on a sale of Shares pursuant to the Offer depends on whether this transaction is “effectively connected” with a trade or business carried on in the U.S. by the Non-U.S. Shareholder (and
if an income tax treaty applies, on whether the Non-U.S. Shareholder maintains a U.S. permanent establishment) as well as the tax characterization of the transaction as either a sale of the Shares or a
dividend distribution by the Company, as discussed above for U.S. Shareholders. If the sale of Shares
9
pursuant to the Offer is not so effectively connected (or, if an income tax treaty applies, the Non-U.S. Shareholder does not maintain a U.S. permanent
establishment) and if, as anticipated for U.S. Shareholders, it gives rise to gain or loss rather than dividend treatment, any gain realized by a Non-U.S. Shareholder upon the tender of Shares pursuant to the
Offer generally will not be subject to U.S. federal income tax or to any U.S. tax withholding; provided, however, that such a gain will be subject to U.S. federal income tax at the rate of 30% (or such lower rate as may be applicable under an income
tax treaty) if the Non-U.S. Shareholder is a non-resident alien individual who is physically present in the United States for more than 182 days during the taxable year
of the sale and certain other conditions exist. If, however, Non-U.S. Shareholders are deemed, for the reasons described above in respect of U.S. Shareholders, to receive a dividend distribution from the
Company with respect to Shares they tender, the portion of the distribution treated as a dividend to the Non-U.S. Shareholder would be subject to a U.S. withholding tax at the rate of 30% (or such lower rate
as may be applicable under a tax treaty) if the dividend is not effectively connected with the conduct of a trade or business in the United States by the Non-U.S. Shareholder (or, if an income tax treaty
applies, the Non-U.S. Shareholder does not maintain a U.S. permanent establishment). The amount of the dividend subject to withholding tax generally would not include any portion of such dividend properly
reported as a capital gain dividend and any portion of such dividend properly reported as an interest-related dividend or short-term capital gain dividend. In addition, if a non-U.S. shareholder is deemed to
receive a dividend, a 30% withholding may be imposed under the “Foreign Account Tax Compliance Act,” or “FATCA,” unless the Non-U.S. Shareholder and the intermediaries through which it
holds its shares comply with the applicable disclosure requirements.
If the amount realized on the tender of Shares by a
Non-U.S. Shareholder is effectively connected with the conduct of a trade or business in the United States by the Non-U.S. Shareholder (and, if an income tax treaty
applies, the Non-U.S. Shareholder maintains a U.S. permanent establishment), regardless of whether the tender is characterized as a sale or as giving rise to a dividend distribution from the Company for U.S.
federal income tax purposes, the transaction will be treated and taxed in the same manner discussed above as if the Shares involved were tendered by a U.S. Shareholder.
Any dividends received by a corporate Non-U.S. Shareholder that are effectively connected with a U.S. trade or
business in which the corporate shareholder is engaged (and if an income tax treaty applies, are attributable to a permanent establishment maintained by the corporate Non-U.S. Shareholder) also may be subject
to an additional branch profits tax at a 30% rate, or lower applicable treaty rate.
Non-U.S. Shareholders should
provide the Company with a properly completed Form W-8BEN, Form 8BEN-E Form W-8IMY, Form
W-8ECI or other applicable form in order to avoid 24% backup withholding on the cash they receive from the Company regardless of how they are taxed with respect to their tender of the Shares involved.
14. Amendments; Extension of Tender Period; Termination.
We reserve the right, at any time during the pendency of the Offer, to amend, supplement, extend or terminate the Offer in any respect. Without limiting the
manner in which we may choose to make a public announcement of such an amendment, supplement, extension or termination, we shall have no obligation to publish, advertise or otherwise communicate any such public announcement, except as provided by
applicable law (including Rules 14e-1(d) and 13e-4(e)(3) promulgated under the Exchange Act).
We may extend the period of time the Offer will be open by issuing a press release or making some other public announcement by no later than 9:00 A.M.,
Eastern Time, on the next business day after the Offer would have expired. Except to the extent required by applicable law (including Rule 13e-4(f)(1) promulgated under the Exchange Act), we will have no
obligation to extend the Offer.
15. Forward Looking Statements; Miscellaneous.
This Offer contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties
and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about Owl Rock Capital Corporation II (the
“Company,” “we” or “our”), our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,”
“plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,”
“outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to
risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without
limitation:
10
| |
• |
|
an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead
to the loss of some or all of our investments in such portfolio companies; |
| |
• |
|
an economic downturn could disproportionately impact the companies that we intend to target for investment,
potentially causing us to experience a decrease in investment opportunities and diminished demand for capital from these companies; |
| |
• |
|
an economic downturn could also impact availability and pricing of our financing and our ability to access the
debt and equity capital markets; |
| |
• |
|
a contraction of available credit and/or an inability to access the equity markets could impair our lending and
investment activities; |
| |
• |
|
the impact of the “COVID-19” pandemic, changes in base interest
rates and significant market volatility on our business and our portfolio companies (including our business prospects and the prospects of our portfolio companies including the ability to achieve our and their business objectives), our industry and
the global economy including as a result of ongoing supply chain disruptions; |
| |
• |
|
interest rate volatility, including the decommissioning of LIBOR, could adversely affect our results,
particularly because we use leverage as part of our investment strategy; |
| |
• |
|
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to
the extent that we receive payments denominated in foreign currency rather than U.S. dollars; |
| |
• |
|
our future operating results; |
| |
• |
|
the impact of rising interest and inflation rates and the risk of recession on our business prospects and the
prospects of our portfolio companies; |
| |
• |
|
our contractual arrangements and relationships with third parties; |
| |
• |
|
the ability of our portfolio companies to achieve their objectives; |
| |
• |
|
competition with other entities and our affiliates for investment opportunities; |
| |
• |
|
the speculative and illiquid nature of our investments; |
| |
• |
|
the use of borrowed money to finance a portion of our investments as well as any estimates regarding potential
use of leverage; |
| |
• |
|
the adequacy of our financing sources and working capital; |
| |
• |
|
the loss of key personnel; |
| |
• |
|
the timing of cash flows, if any, from the operations of our portfolio companies; |
| |
• |
|
the ability of the Adviser to locate suitable investments for us and to monitor and administer our investments;
|
| |
• |
|
the ability of the Adviser to attract and retain highly talented professionals; |
| |
• |
|
our ability to maintain our tax treatment as a RIC under Subchapter M of the Code, and as a BDC;
|
| |
• |
|
the impact that environmental, social and governance matters could have on our brand and reputation and our
portfolio companies; |
| |
• |
|
the effect of legal, tax and regulatory changes, including the Inflation Reduction Act of 2022;
|
| |
• |
|
the impact of geo-political conditions, including revolution, insurgency,
terrorism or war, including those arising out of the ongoing war between Russia and Ukraine and general uncertainty surrounding the financial and political stability of the United States, the United Kingdom, the European Union and China; and
|
| |
• |
|
other risks, uncertainties and other factors previously identified in the reports and other documents we have
filed with the SEC. |
Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of
those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking
statement in this Offer should not be regarded as a representation by us that our plans and objectives will be achieved. These forward-looking statements apply only as of the date of this Offer. Moreover, we assume no duty and do not undertake to
update the forward-looking statements. Because we are an investment company, the forward-looking statements and projections contained in this Offer are excluded from the safe harbor protection provided by Section 21E of the Exchange Act.
11
The Offer is not being made to, nor will we accept tenders from, or on behalf of, owners of Shares in any
jurisdiction in which the making of the Offer or its acceptance would not comply with the securities or “blue sky” laws of that jurisdiction. We are not aware of any jurisdiction in which the making of the Offer or the acceptance of
tenders of, purchase of, or payment for, Shares in accordance with the Offer would not be in compliance with the laws of such jurisdiction. We, however, reserve the right to exclude shareholders in any jurisdiction in which it is asserted that the
Offer cannot lawfully be made or tendered Shares cannot lawfully be accepted, purchased or paid for. So long as we make a good-faith effort to comply with any state law deemed applicable to the Offer, we believe that the exclusion of holders
residing in any such jurisdiction is permitted under Rule 13e-4(f)(9) promulgated under the Exchange Act.
February 21, 2023
OWL ROCK CAPITAL
CORPORATION II
12
